Published in
Taylor and Francis Group, Acta Oncologica, 1(60), p. 69-77, 2020
DOI: 10.1080/0284186x.2020.1818823
Links
Tools
Health-related quality of life of long-term advanced melanoma survivors treated with anti-CTLA-4 immune checkpoint inhibition compared to matched controls
Journal article published in 2020 by
A. H. Boekhout 
,
A. Rogiers ,
K. Jozwiak,
M. J. Boers-Sonderen,
A. J. van den Eertwegh,
G. A. Hospers,
J. W. B. de Groot,
M. J. B. Aarts,
E. Kapiteijn,
A. J. ten Tije,
D. Piersma,
G. Vreugdenhil,
A. A. van der Veldt,
K. P. M. Suijkerbuijk ,
E. A. Rozeman
and other authors.
,
A. Rogiers ,
K. Jozwiak,
M. J. Boers-Sonderen,
A. J. van den Eertwegh,
G. A. Hospers,
J. W. B. de Groot,
M. J. B. Aarts,
E. Kapiteijn,
A. J. ten Tije,
D. Piersma,
G. Vreugdenhil,
A. A. van der Veldt,
K. P. M. Suijkerbuijk ,
E. A. Rozeman
and other authors.
Distributing this paper is prohibited by the publisher
Full text: Unavailable
Preprint: archiving forbidden
Published version:
archiving forbidden
Data provided by 